This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.15% per year. These returns cover a period from January 1, 1988 through June 3, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Parker-Hannifin (PH) Q4 Earnings Beat, Increase 18% Y/Y
by Zacks Equity Research
Parker-Hannifin's (PH) fiscal Q4 results benefit from the contribution of Meggitt acquisition and operational improvement.
Johnson Controls (JCI) Q3 Earnings In Line, Revenues Rise Y/Y
by Zacks Equity Research
Johnson Controls' (JCI) fiscal Q3 results benefit from strength in the HVAC & Controls and Fire & Security businesses.
Xylem (XYL) Q2 Earnings & Revenues Top Estimates, '23 View Up
by Zacks Equity Research
Xylem's (XYL) Q2 results benefit from strong commercial and operational execution and contribution from the Evoqua acquisition. Following strong performance, the company raises its 2023 guidance.
Zebra Technologies (ZBRA) Q2 Earnings Beat, '23 View Bearish
by Zacks Equity Research
Despite surpassing earnings estimates, Zebra Technologies' (ZBRA) Q2 results are hurt by lower demand and reduced consumer spending. As a result, the company provides a bleak outlook for Q3 and 2023.
Illinois Tool (ITW) Beats on Q2 Earnings, Raises '23 EPS View
by Zacks Equity Research
Illinois Tool's (ITW) Q2 results benefit from organic sales growth. Anticipating stable underlying demand for the rest of 2023, the company improves its earnings guidance for 2023.
Graco (GGG) Q2 Earnings Miss Estimates, Revenues Rise Y/Y
by Zacks Equity Research
Graco's (GGG) Q2 revenues increase 2% year over year, driven by double-digit growth in the Process segment.
A. O. Smith (AOS) Beats on Q2 Earnings, Revises 2023 View
by Zacks Equity Research
A. O. Smith's (AOS) Q2 results benefit from the continued demand for North America commercial and residential water heater products. The company hikes its earnings guidance for 2023.
IDEX (IEX) Q2 Earnings Beat Estimates, Lowers 2023 EPS View
by Zacks Equity Research
IDEX's (IEX) Q2 earnings results reflect gains from solid segmental performances. However, the company lowered its earnings guidance for 2023.
Here's What Key Metrics Tell Us About Idex (IEX) Q2 Earnings
by Zacks Equity Research
While the top- and bottom-line numbers for Idex (IEX) give a sense of how the business performed in the quarter ended June 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Idex (IEX) Q2 Earnings Beat Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 2.83% and 0.14%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
What's in the Cards for IDEX (IEX) This Earnings Season?
by Zacks Equity Research
Softness across pharma, biopharma and nutrition end markets within the material processing technology business is likely to have hurt IDEX's (IEX) Q2 performance.
DOV vs. IEX: Which Stock Is the Better Value Option?
by Zacks Equity Research
DOV vs. IEX: Which Stock Is the Better Value Option?
Should Vanguard Small-Cap Value ETF (VBR) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VBR
5 Stocks to Watch on Dividend Hikes Amid Economic Turmoil
by Zacks Equity Research
Investors may keep a tab on stocks like LOW, NTES, CM, HLNE and IEX, which have lately hiked their dividend payments.
Should Vanguard Small-Cap ETF (VB) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for VB
IDEX's (IEX) 5.9% Gain in One Year Raises Longevity Questions
by Zacks Equity Research
IDEX (IEX) benefits from strength in its Fluid & Metering Technologies segment and growth investments. Its shareholder-friendly measures are encouraging.
Why Is Idex (IEX) Down 2.9% Since Last Earnings Report?
by Zacks Equity Research
Idex (IEX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
IDEX (IEX) Cheers Investors With 7% Quarterly Dividend Hike
by Zacks Equity Research
IDEX (IEX) increases its quarterly dividend by 7% to 64 cents per share. IDEX is also active on the buyback front.
IDEX (IEX) Boosts Optical Portfolio With Iridian Buyout
by Zacks Equity Research
IDEX (IEX) completes the Iridian acquisition, expanding its wide array of optical technology offerings. The acquired entity is part of the Health & Science Technology segment.
IDEX (IEX) Q1 Earnings & Revenues Beat, Increase Y/Y
by Zacks Equity Research
IDEX's (IEX) Q1 earnings results reflect gains from solid segmental performances.
Idex (IEX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Idex (IEX) give a sense of how its business performed in the quarter ended March 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Idex (IEX) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Idex (IEX) delivered earnings and revenue surprises of 2.96% and 3.44%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
PH or IEX: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
PH vs. IEX: Which Stock Is the Better Value Option?
Flowserve (FLS) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Flowserve (FLS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
What's in the Cards for IDEX (IEX) This Earnings Season?
by Zacks Equity Research
IDEX's (IEX) Q1 performance is likely to have been aided by strength in its Fluid & Metering Technologies segment, partly offset by unfavorable price/cost impacts and higher discretionary expenses.